156.00 (-%)
As of Nov 20, 2024
Source:
Biogen is a global biopharmaceutical company focused on discovering, developing and delivering innovative therapies for people living with serious and complex diseases worldwide. We have a broad portfolio of medicines to treat multiple sclerosis (MS), have introduced the first approved treatment for spinal muscular atrophy (SMA) and co-developed two treatments to address a defining pathology of Alzheimer’s disease.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | 7814642000 |
Industry | manufacturing |
CEO | Christopher A. Viehbacher |
Website | www.biogen.com |